{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:55:11Z","timestamp":1789692911194,"version":"4.0.1"},"reference-count":248,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Carbohydrate Polymers"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.carbpol.2024.122402","type":"journal-article","created":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T13:51:43Z","timestamp":1718545903000},"page":"122402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Impact of glycosylation on viral vaccines"],"prefix":"10.1016","volume":"342","author":[{"given":"Antonio","family":"Lembo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Molinaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"De Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Biagini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.carbpol.2024.122402_bb0005","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1128\/JVI.00647-07","article-title":"Immunogenicity of influenza virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting cells","volume":"81","author":"Abdel-Motal","year":"2007","journal-title":"Journal of Virology"},{"issue":"27","key":"10.1016\/j.carbpol.2024.122402_bb0010","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1021\/acs.biochem.1c00279","article-title":"Site-specific steric control of SARS-CoV-2 spike glycosylation","volume":"60","author":"Allen","year":"2021","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122402_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2023.112307","article-title":"The diversity of the glycan shield of sarbecoviruses closely related to SARS-CoV-2","volume":"42","author":"Allen","year":"2023","journal-title":"Cell Reports"},{"issue":"10","key":"10.1016\/j.carbpol.2024.122402_bb0020","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1021\/acschembio.6b00460","article-title":"Facile modulation of antibody Fucosylation with small molecule fucostatin inhibitors and cocrystal structure with GDP-mannose 4,6-dehydratase","volume":"11","author":"Allen","year":"2016","journal-title":"ACS Chemical Biology"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122402_bb0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000096114","article-title":"The role of protein glycosylation in allergy","volume":"142","author":"Altmann","year":"2007","journal-title":"International Archives of Allergy and Immunology"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122402_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.01693-18","article-title":"N-glycosylation of seasonal influenza vaccine hemagglutinins: Implication for potency testing and immune processing","volume":"93","author":"An","year":"2019","journal-title":"Journal of Virology"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb0035","article-title":"O-glycosylated HBsAg peptide can induce specific antibody neutralizing HBV infection","volume":"1866","author":"Angata","year":"2022","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.carbpol.2024.122402_bb0040","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1126\/science.abm0271","article-title":"A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes","volume":"378","author":"Arevalo","year":"2022","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb0045","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41541-021-00403-7","article-title":"Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance","volume":"6","author":"Arunachalam","year":"2021","journal-title":"npj Vaccines"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/s43586-022-00128-4","article-title":"Glycoproteomics","volume":"2","author":"Bagdonaite","year":"2022","journal-title":"Nature Reviews Methods Primers"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122402_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004784","article-title":"A strategy for O-glycoproteomics of enveloped viruses--the O-glycoproteome of herpes simplex virus type 1","volume":"11","author":"Bagdonaite","year":"2015","journal-title":"PLoS Pathogens"},{"issue":"23","key":"10.1016\/j.carbpol.2024.122402_bb0060","doi-asserted-by":"crossref","first-page":"12014","DOI":"10.1074\/jbc.M116.721746","article-title":"Global mapping of O-glycosylation of varicella zoster virus, human cytomegalovirus, and Epstein-Barr virus","volume":"291","author":"Bagdonaite","year":"2016","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/j.carbpol.2024.122402_bb0065","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12033-019-00164-8","article-title":"Yeast expression systems: Overview and recent advances","volume":"61","author":"Baghban","year":"2019","journal-title":"Molecular Biotechnology"},{"issue":"10","key":"10.1016\/j.carbpol.2024.122402_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115463","article-title":"Chemical reactivity and uses of 1-phenyl-3-methyl-5-pyrazolone (PMP), also known as edaravone","volume":"28","author":"Bailly","year":"2020","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.carbpol.2024.122402_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.629090","article-title":"Outer membrane vesicle induction and isolation for vaccine development","volume":"12","author":"Balhuizen","year":"2021","journal-title":"Frontiers in Microbiology"},{"key":"10.1016\/j.carbpol.2024.122402_bb0080","series-title":"Glycoprotein Monosaccharide Analysis Using HPAE-PAD with Eluent Generation","first-page":"1","author":"Basumallick","year":"2016"},{"issue":"11","key":"10.1016\/j.carbpol.2024.122402_bb0085","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/j.celrep.2016.02.058","article-title":"Composition and antigenic effects of individual glycan sites of a trimeric HIV-1 envelope glycoprotein","volume":"14","author":"Behrens","year":"2016","journal-title":"Cell Reports"},{"key":"10.1016\/j.carbpol.2024.122402_bb0090","series-title":"Carbohydrate Based Vaccines","author":"Berti","year":"2015"},{"issue":"21","key":"10.1016\/j.carbpol.2024.122402_bb0095","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1007\/s00216-015-8810-3","article-title":"Structural characterization of major soyasaponins in traditional cultivars of Fagioli di Sarconi beans investigated by high-resolution tandem mass spectrometry","volume":"407","author":"Bianco","year":"2015","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"1\u221212","key":"10.1016\/j.carbpol.2024.122402_bb0100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/bms.1200160119","article-title":"Contributions of mass spectrometry to peptide and protein structure","volume":"16","author":"Biemann","year":"1988","journal-title":"Biomedical and Environmental Mass Spectrometry"},{"key":"10.1016\/j.carbpol.2024.122402_bb0105","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41589-022-01219-9","article-title":"Structure, sequon recognition and mechanism of tryptophan C-mannosyltransferase","volume":"19","author":"Bloch","year":"2023","journal-title":"Nature Chemical Biology"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122402_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/plants9020162","article-title":"Plant-produced recombinant influenza A virus candidate vaccine based on flagellin linked to conservative fragments of M2 protein and hemagglutintin","volume":"9","author":"Blokhina","year":"2020","journal-title":"Plants"},{"key":"10.1016\/j.carbpol.2024.122402_bb0115","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0264-410X(01)00358-9","article-title":"Enhanced immunogenicity ofa human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals effects of elimination of the V3 N306 glycan","volume":"20","author":"Bolmstedt","year":"2002","journal-title":"Vaccine"},{"issue":"6556","key":"10.1016\/j.carbpol.2024.122402_bb0120","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1126\/science.abf5375","article-title":"Plant made vaccines and therapeutics","volume":"373","author":"Bovendo","year":"2021","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.carbpol.2024.122402_bb0125","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1258\/jrsm.2012.12k044","article-title":"The origins of inoculation","volume":"105","author":"Boylston","year":"2012","journal-title":"Journal of the Royal Society of Medicine"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb0130","article-title":"A class of low-cost alternatives to kifunensine for increasing high mannose N-linked glycosylation for monoclonal antibody production in Chinese hamster ovary cells","volume":"37","author":"Brantley","year":"2021","journal-title":"Biotechnolgy Progress"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122402_bb0135","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0042-6822(03)00008-4","article-title":"Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine","volume":"308","author":"Bright","year":"2003","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122402_bb0140","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1021\/acscentsci.1c00058","article-title":"Assessing antigen structural integrity through glycosylation analysis of the SARS-CoV-2 viral spike","volume":"7","author":"Brun","year":"2021","journal-title":"ACS Central Science"},{"issue":"5","key":"10.1016\/j.carbpol.2024.122402_bb0145","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1021\/cb501023u","article-title":"Synthesis and microarray-assisted binding studies of core xylose and fucose containing N-glycans","volume":"10","author":"Brzezicka","year":"2015","journal-title":"ACS Chemical Biology"},{"key":"10.1016\/j.carbpol.2024.122402_bb0150","series-title":"Nature Milestones","article-title":"First recombinant DNA vaccine for HBV","author":"Bucci","year":"2020"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122402_bb0155","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/aid.1994.10.359","article-title":"Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization","volume":"10","author":"Buchacher","year":"1994","journal-title":"AIDS Research and Human Retroviruses"},{"issue":"10","key":"10.1016\/j.carbpol.2024.122402_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005227","article-title":"Crystal structure of the human cytomegalovirus glycoprotein B","volume":"11","author":"Burke","year":"2015","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.carbpol.2024.122402_bb0165","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.carres.2012.01.017","article-title":"NMR structural analysis of the capsular polysaccharide from Streptococcus pneumoniae serotype 6C","volume":"351","author":"Cai","year":"2012","journal-title":"Carbohydrate Research"},{"key":"10.1016\/j.carbpol.2024.122402_bb0170","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1126\/science.1083182","article-title":"Antibody domain exchange is an immunological solution to carbohydrate cluster recognition","volume":"300","author":"Calarese","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.carbpol.2024.122402_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14954","article-title":"Global site-specific N-glycosylation analysis of HIV envelope glycoprotein","volume":"8","author":"Cao","year":"2017","journal-title":"Nature Communications"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122402_bb0180","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/cei.13614","article-title":"Therapeutic vaccination for treatment of chronic hepatitis B","volume":"205","author":"Cargill","year":"2021","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.carbpol.2024.122402_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1118523","article-title":"Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants","volume":"14","author":"Carnell","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122402_bb0190","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nm.4268","article-title":"Antibody 10-1074 suppresses viremia in HIV-1-infected individuals","volume":"23","author":"Caskey","year":"2017","journal-title":"Nature Medicine"},{"issue":"12","key":"10.1016\/j.carbpol.2024.122402_bb0195","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1074\/mcp.R119.001491","article-title":"Why glycosylation matters in building a better flu vaccine","volume":"18","author":"Chang","year":"2019","journal-title":"Molecular & Cellular Proteomics"},{"issue":"11","key":"10.1016\/j.carbpol.2024.122402_bb0200","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: Principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nature Reviews Drug Discovery"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122402_bb0205","article-title":"Laboratory diagnosis of HbA1c: A review","volume":"5","author":"Chauhan","year":"2017","journal-title":"Journal of Nano Research"},{"key":"10.1016\/j.carbpol.2024.122402_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2022.102402","article-title":"Principles of SARS-CoV-2 glycosylation","volume":"75","author":"Chawla","year":"2022","journal-title":"Current Opinion in Structural Biology"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12929-020-0626-6","article-title":"Better influenza vaccines: An industry perspective","volume":"27","author":"Chen","year":"2020","journal-title":"Journal of Biomedical Science"},{"issue":"7","key":"10.1016\/j.carbpol.2024.122402_bb0220","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1073\/pnas.1323954111","article-title":"Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections","volume":"111","author":"Chen","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.carbpol.2024.122402_bb0225","article-title":"Site-specific glycan-masking\/unmasking hemagglutinin antigen design to elicit broadly neutralizing and stem-binding antibodies against highly pathogenic avian influenza H5N1 virus infections","volume":"12","author":"Chen","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"49","key":"10.1016\/j.carbpol.2024.122402_bb0230","doi-asserted-by":"crossref","first-page":"16618","DOI":"10.1021\/acs.analchem.1c04031","article-title":"Highly efficient enrichment of O-GlcNAc Glycopeptides based on chemical oxidation and reversible hydrazide chemistry","volume":"93","author":"Chen","year":"2021","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.carbpol.2024.122402_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114757","article-title":"Enhancing pharmacokinetic and pharmacodynamic properties of recombinant therapeutic proteins by manipulation of sialic acid content","volume":"163","author":"Chia","year":"2023","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122402_bb0240","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.alit.2019.04.001","article-title":"Alpha-gal-containing biologics and anaphylaxis","volume":"68","author":"Chinuki","year":"2019","journal-title":"Allergology International"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34438-z","article-title":"N-glycan remodeling using mannosidase inhibitors to increase high-mannose glycans on acid alpha-glucosidase in transgenic rice cell cultures","volume":"8","author":"Choi","year":"2018","journal-title":"Scientific Reports"},{"issue":"6","key":"10.1016\/j.carbpol.2024.122402_bb0250","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1073\/pnas.1424818112","article-title":"Structural and biochemical studies of HCMV gH\/gL\/gO and Pentamer reveal mutually exclusive cell entry complexes","volume":"112","author":"Ciferri","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122402_bb0255","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.chembiol.2011.12.019","article-title":"A bacterial lipooligosaccharide that naturally mimics the epitope of the HIV-neutralizing antibody 2G12 as a template for vaccine design","volume":"19","author":"Clark","year":"2012","journal-title":"Chemistry & Biology"},{"issue":"5","key":"10.1016\/j.carbpol.2024.122402_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2020.107991","article-title":"Sialyl-Lewis(X) glycoantigen is enriched on cells with persistent HIV transcription during therapy","volume":"32","author":"Colomb","year":"2020","journal-title":"Cell Reports"},{"issue":"37","key":"10.1016\/j.carbpol.2024.122402_bb0265","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1016\/j.vaccine.2018.07.056","article-title":"Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response","volume":"36","author":"Cui","year":"2018","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.carbpol.2024.122402_bb0270","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1039\/b713816d","article-title":"Glycopeptide analysis by mass spectrometry","volume":"133","author":"Dalpathado","year":"2008","journal-title":"Analyst"},{"key":"10.1016\/j.carbpol.2024.122402_bb0275","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/bs.ai.2019.08.002","article-title":"Antibody responses to the HIV-1 envelope high mannose patch","volume":"143","author":"Daniels","year":"2019","journal-title":"Advances in Immunology"},{"key":"10.1016\/j.carbpol.2024.122402_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104586","article-title":"Inhibition of N-linked glycosylation by Tunicamycin may contribute to the treatment of SARS-CoV-2","volume":"149","author":"Dawood","year":"2020","journal-title":"Microbial Pathogenesis"},{"key":"10.1016\/j.carbpol.2024.122402_bb0285","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0076-6879(10)80005-9","article-title":"Microbe-associated molecular patterns in innate immunity: Extraction and chemical analysis of gram-negative bacterial lipopolysaccharides","volume":"480","author":"De Castro","year":"2010","journal-title":"Methods in Enzymology"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122402_bb0290","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/anie.201509150","article-title":"N-linked glycans of chloroviruses sharing a core architecture without precedent","volume":"55","author":"De Castro","year":"2016","journal-title":"Angewandte Chemie International Edition"},{"key":"10.1016\/j.carbpol.2024.122402_bb0295","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: A review on adjuvants in licensed vaccines","volume":"39","author":"Del Giudice","year":"2018","journal-title":"Seminars in Immunology"},{"issue":"47","key":"10.1016\/j.carbpol.2024.122402_bb0300","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1016\/j.vaccine.2022.09.057","article-title":"Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation","volume":"40","author":"Deng","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108933","article-title":"Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike","volume":"35","author":"Derking","year":"2020","journal-title":"Cell Reports"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122402_bb0310","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/bit.26498","article-title":"cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV-1 envelope glycoprotein vaccine candidate","volume":"115","author":"Dey","year":"2018","journal-title":"Biotechnology and Bioengineering"},{"issue":"20","key":"10.1016\/j.carbpol.2024.122402_bb0315","doi-asserted-by":"crossref","first-page":"15767","DOI":"10.1021\/acs.chemrev.0c01321","article-title":"A journey from structure to function of bacterial lipopolysaccharides","volume":"122","author":"Di Lorenzo","year":"2022","journal-title":"Chemical Reviews"},{"issue":"29","key":"10.1016\/j.carbpol.2024.122402_bb0320","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1016\/j.vaccine.2021.05.067","article-title":"Assessment of immunogenicity and safety across two manufacturing lots of a 3-antigen hepatitis B vaccine, Sci-B-Vac(R), compared with Engerix-B(R) in healthy Asian adults: A phase 3 randomized clinical trial","volume":"39","author":"Diaz-Mitoma","year":"2021","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.carbpol.2024.122402_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14712598.2015.1069271","article-title":"Using glyco-engineering to produce therapeutic proteins","volume":"15","author":"Dicker","year":"2015","journal-title":"Expert Opinion on Biological Therapy"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb0330","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14760584.2016.1213632","article-title":"Adjuvant system AS01: Helping to overcome the challenges of modern vaccines","volume":"16","author":"Didierlaurent","year":"2017","journal-title":"Expert Review of Vaccines"},{"issue":"6","key":"10.1016\/j.carbpol.2024.122402_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells9061404","article-title":"N-glycosylation and N-glycan processing in HBV biology and pathogenesis","volume":"9","author":"Dobrica","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.carbpol.2024.122402_bb0340","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/d41573-022-00074-6","article-title":"Pan-coronavirus vaccine pipeline takes form","volume":"21","author":"Dolgin","year":"2022","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.carbpol.2024.122402_bb0345","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF01049915","article-title":"A systematic nomenclature for carbohydrate fragmentations in FAB-MS\/MS spectra of glycoconjugates","volume":"5","author":"Domon","year":"1988","journal-title":"Glycoconjugate"},{"key":"10.1016\/j.carbpol.2024.122402_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2022.340394","article-title":"Systematic analysis and comparison of O-glycosylation of five recombinant spike proteins in beta-coronaviruses","volume":"1230","author":"Dong","year":"2022","journal-title":"Analytica Chimica Acta"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122402_bb0355","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1042\/BST20200840","article-title":"Glycoengineering Chinese hamster ovary cells: A short history","volume":"49","author":"Donini","year":"2021","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.carbpol.2024.122402_bb0360","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.immunol.15.1.617","article-title":"DNA vaccines","volume":"15","author":"Donnelly","year":"1997","journal-title":"Annual Review of Immunology"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb0365","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12250-020-00283-6","article-title":"Flu universal vaccines: New tricks on an old virus","volume":"36","author":"Du","year":"2021","journal-title":"Virologica Sinica"},{"issue":"5","key":"10.1016\/j.carbpol.2024.122402_bb0370","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/chem.201002519","article-title":"A solution NMR study of the interactions of oligomannosides and the anti-HIV-1 2G12 antibody reveals distinct binding modes for branched ligands","volume":"17","author":"Enriquez-Navas","year":"2011","journal-title":"Chemistry"},{"issue":"28","key":"10.1016\/j.carbpol.2024.122402_bb0375","doi-asserted-by":"crossref","first-page":"10101","DOI":"10.1021\/acs.analchem.2c01181","article-title":"Identification of mobility-resolved N-glycan isomers","volume":"94","author":"Faleh","year":"2022","journal-title":"Analytical Chemistry"},{"issue":"5","key":"10.1016\/j.carbpol.2024.122402_bb0380","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.immuni.2014.04.009","article-title":"Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers","volume":"40","author":"Falkowska","year":"2014","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb0385","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.virol.2007.06.015","article-title":"Ebola sGP--the first viral glycoprotein shown to be C-mannosylated","volume":"368","author":"Falzarano","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.carbpol.2024.122402_bb0390","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijbiomac.2018.12.033","article-title":"A rapid, accurate and sensitive method for determination of monosaccharides in different varieties of Osmanthus fragrans Lour by pre-column derivatization with HPLC-MS\/MS","volume":"125","author":"Fan","year":"2019","journal-title":"International Journal of Biological Macromolecules"},{"issue":"11","key":"10.1016\/j.carbpol.2024.122402_bb0395","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41573-019-0037-0","article-title":"Therapeutic strategies for hepatitis B virus infection: Towards a cure","volume":"18","author":"Fanning","year":"2019","journal-title":"Nature Reviews Drug Discovery"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb0400","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1080\/21505594.2022.2060464","article-title":"Glycosylation of viral proteins: Implication in virus-host interaction and virulence","volume":"13","author":"Feng","year":"2022","journal-title":"Virulence"},{"issue":"31","key":"10.1016\/j.carbpol.2024.122402_bb0405","doi-asserted-by":"crossref","first-page":"12669","DOI":"10.1073\/pnas.1108455108","article-title":"Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose","volume":"108","author":"Ferrara","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb0410","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1038\/s41467-020-18464-y","article-title":"Structural and mechanistic basis of capsule O-acetylation in Neisseria meningitidis serogroup A","volume":"11","author":"Fiebig","year":"2020","journal-title":"Nature Communications"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122402_bb0415","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1021\/acs.chemrev.2c00580","article-title":"Primary structure of Glycans by NMR spectroscopy","volume":"123","author":"Fontana","year":"2023","journal-title":"Chemical Reviews"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122402_bb0420","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0264-410X(95)00189-8","article-title":"Enhancement of antigen presentation of influenza virus hemagglutinin by the natural human anti-gal antibody","volume":"14","author":"Galili","year":"1995","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb0425","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2014.09.009","article-title":"Structural evolution of glycan recognition by a family of potent HIV antibodies","volume":"159","author":"Garces","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.carbpol.2024.122402_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107970","article-title":"Lipopolysaccharide lipid A: A promising molecule for new immunity-based therapies and antibiotics","volume":"230","author":"Garcia-Vello","year":"2022","journal-title":"Pharmacology & Therapeutics"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122402_bb0435","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1044-0305(02)00913-3","article-title":"Top down characterization of secreted proteins from Mycobacterium tuberculosis by electron capture dissociation mass spectrometry","volume":"14","author":"Ge","year":"2003","journal-title":"Journal of the American Society for Mass Spectrometry"},{"key":"10.1016\/j.carbpol.2024.122402_bb0440","series-title":"Post-translational modification of protein biopharmaceuticals","first-page":"165","article-title":"Insect cell glycosylation patterns in the context of biopharmaceuticals","author":"Geisler","year":"2009"},{"key":"10.1016\/j.carbpol.2024.122402_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102281","article-title":"Anti-glycan monoclonal antibodies: Basic research and clinical applications","volume":"74","author":"Gillmann","year":"2023","journal-title":"Current Opinion in Chemical Biology"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122402_bb0450","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.tvjl.2011.08.005","article-title":"Deletion of the single putative N-glycosylation site of the porcine circovirus type 2 Cap protein enhances specific immune responses by DNA immunisation in mice","volume":"192","author":"Gu","year":"2012","journal-title":"The Veterinary Journal"},{"issue":"9","key":"10.1016\/j.carbpol.2024.122402_bb0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v12090925","article-title":"N-glycosylation in the pre-membrane protein is essential for the Zika virus life cycle","volume":"12","author":"Gwon","year":"2020","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.carbpol.2024.122402_bb0460","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s13361-016-1419-8","article-title":"Combined infrared multiphoton dissociation with ultraviolet Photodissociation for ubiquitin characterization","volume":"27","author":"Halim","year":"2016","journal-title":"Journal of the American Society for Mass Spectrometry"},{"key":"10.1016\/j.carbpol.2024.122402_bb0465","series-title":"Vaccination strategies against highly variable pathogens","author":"Hangartner","year":"2018"},{"issue":"8","key":"10.1016\/j.carbpol.2024.122402_bb0470","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1002\/bit.27361","article-title":"Glycosylation as a tool for rational vaccine design","volume":"117","author":"Hariharan","year":"2020","journal-title":"Biotechnology and Bioengineering"},{"issue":"22","key":"10.1016\/j.carbpol.2024.122402_bb0475","doi-asserted-by":"crossref","first-page":"11905","DOI":"10.1128\/JVI.01548-10","article-title":"Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions","volume":"84","author":"Helle","year":"2010","journal-title":"Journal of Virology"},{"issue":"5","key":"10.1016\/j.carbpol.2024.122402_bb0480","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/S1470-2045(14)70481-4","article-title":"Present status of human papillomavirus vaccine development and implementation","volume":"16","author":"Herrero","year":"2015","journal-title":"The Lancet Oncology"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122402_bb0485","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.4049\/jimmunol.178.4.2361","article-title":"Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN","volume":"178","author":"Hervas-Stubbs","year":"2007","journal-title":"The Journal of Immunology"},{"issue":"12","key":"10.1016\/j.carbpol.2024.122402_bb0490","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.pt.2020.08.001","article-title":"Alpha-gal-based vaccines: Advances, opportunities, and perspectives","volume":"36","author":"Hodzic","year":"2020","journal-title":"Trends in Parasitology"},{"key":"10.1016\/j.carbpol.2024.122402_bb0495","series-title":"Mass Spectrometry: Applications and Principles","author":"de Hoffmann","year":"2007"},{"issue":"12","key":"10.1016\/j.carbpol.2024.122402_bb0500","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1002\/bit.25670","article-title":"Expression of the human cytomegalovirus pentamer complex for vaccine use in a CHO system","volume":"112","author":"Hofmann","year":"2015","journal-title":"Biotechnology and Bioengineering"},{"key":"10.1016\/j.carbpol.2024.122402_bb0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.abm0899","article-title":"Vaccination SARS CoV 2 laking glycan shields elicits enhanced protective responses in animal models","volume":"14","author":"Huang","year":"2022","journal-title":"Science Translational Medicine"},{"issue":"12","key":"10.1016\/j.carbpol.2024.122402_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph15121542","article-title":"Hepatitis B therapeutic vaccine: A patent review","volume":"15","author":"Hudu","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"13","key":"10.1016\/j.carbpol.2024.122402_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110611","article-title":"Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans","volume":"38","author":"Huettner","year":"2022","journal-title":"Cell Reports"},{"issue":"22","key":"10.1016\/j.carbpol.2024.122402_bb0520","doi-asserted-by":"crossref","first-page":"11312","DOI":"10.1128\/JVI.01123-15","article-title":"Modification of asparagine-linked glycan density for the design of hepatitis B virus virus-like particles with enhanced immunogenicity","volume":"89","author":"Hyakumura","year":"2015","journal-title":"Journal of Virology"},{"issue":"9","key":"10.1016\/j.carbpol.2024.122402_bb0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells9091986","article-title":"Protein glycosylation investigated by mass spectrometry: An overview","volume":"9","author":"Illiano","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb0530","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"14","key":"10.1016\/j.carbpol.2024.122402_bb0535","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1042\/BCJ20170111","article-title":"Role of glycosylation in nucleating protein folding and stability","volume":"474","author":"Jayaprakash","year":"2017","journal-title":"Biochemical Journal"},{"issue":"22","key":"10.1016\/j.carbpol.2024.122402_bb0540","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1016\/j.vaccine.2020.03.007","article-title":"Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity","volume":"38","author":"Joe","year":"2020","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.carbpol.2024.122402_bb0545","doi-asserted-by":"crossref","first-page":"9049","DOI":"10.1128\/JVI.01161-14","article-title":"Modification of the hepatitis B virus envelope protein glycosylation pattern interferes with secretion of viral particles, infectivity, and susceptibility to neutralizing antibodies","volume":"88","author":"Julithe","year":"2014","journal-title":"Journal of Virology"},{"key":"10.1016\/j.carbpol.2024.122402_bb0550","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/infdis\/169.2.399","article-title":"Immunogenicity of the recombinant GenHevac B Pasteur vaccine against hepatitis B in chronic uremic patients","volume":"169","author":"Jungers","year":"1994","journal-title":"The Journal of lnfectious Diseases"},{"key":"10.1016\/j.carbpol.2024.122402_bb0555","first-page":"1","article-title":"Strategies for the structural analysis of carbohydrates","volume":"2","author":"Kamerling","year":"2007","journal-title":"Comprehensive Glycoscience"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122402_bb0560","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Kariko","year":"2005","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122402_bb0565","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1021\/acs.jproteome.9b00620","article-title":"Spontaneous glycan reattachment following N-Glycanase treatment of influenza and HIV vaccine antigens","volume":"19","author":"Keating","year":"2020","journal-title":"Journal of Proteome Research"},{"issue":"10","key":"10.1016\/j.carbpol.2024.122402_bb0570","first-page":"1884","article-title":"CH-pi interactions in glycan recognition","volume":"16","author":"Kiessling","year":"2021","journal-title":"American Chemical Society Chemical Biology"},{"issue":"12","key":"10.1016\/j.carbpol.2024.122402_bb0575","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1093\/cid\/ciac580","article-title":"Duration of protection after vaccination against yellow fever: A systematic review and Meta-analysis","volume":"75","author":"Kling","year":"2022","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122402_bb0580","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nri1329","article-title":"Immunotherapeutic uses of CpG oligodeoxynucleotides","volume":"4","author":"Klinman","year":"2004","journal-title":"Nature Reviews Immunology"},{"issue":"7","key":"10.1016\/j.carbpol.2024.122402_bb0585","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/nprot.2012.062","article-title":"Determination of site-specific glycan heterogeneity on glycoproteins","volume":"7","author":"Kolarich","year":"2012","journal-title":"Nature Protocols"},{"key":"10.1016\/j.carbpol.2024.122402_bb0590","series-title":"Anticarbohydrate antibodies","author":"Kosma","year":"2012"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb0595","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jcc.26073","article-title":"Systematic interaction analysis of anti-human immunodeficiency virus Type-1 neutralizing antibodies with high mannose glycans using fragment molecular orbital and molecular dynamics methods","volume":"41","author":"Kusumoto","year":"2020","journal-title":"Journal of Computational Chemistry"},{"issue":"7807","key":"10.1016\/j.carbpol.2024.122402_bb0600","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122402_bb0605","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/mas.20012","article-title":"Activation of large ions in FT-ICR mass spectrometry","volume":"24","author":"Laskin","year":"2005","journal-title":"Mass Spectrometry Reviews"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122402_bb0610","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009407","article-title":"A cross-neutralizing antibody between HIV-1 and influenza virus","volume":"17","author":"Lee","year":"2021","journal-title":"PLoS Pathogens"},{"issue":"8","key":"10.1016\/j.carbpol.2024.122402_bb0615","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/anie.200353105","article-title":"Reactivity-based one-pot synthesis of oligomannoses: Defining antigens recognized by 2G12, a broadly neutralizing anti-HIV-1 antibody","volume":"43","author":"Lee","year":"2004","journal-title":"Angewandte Chemie International Edition"},{"issue":"9","key":"10.1016\/j.carbpol.2024.122402_bb0620","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1007\/s00253-021-11247-5","article-title":"Comparison of N-linked glycosylation on hemagglutinins derived from chicken embryos and MDCK cells: a case of the production of a trivalent seasonal influenza vaccine","volume":"105","author":"Li","year":"2021","journal-title":"Applied Microbiology and Biotechnology"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122402_bb0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antib10040044","article-title":"Glycoengineering of therapeutic antibodies with small molecule inhibitors","volume":"10","author":"Li","year":"2021","journal-title":"Antibodies"},{"key":"10.1016\/j.carbpol.2024.122402_bb0630","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.talanta.2019.01.093","article-title":"Validation of Rapi-Fluor method for glycan profiling and application to commercial antibody drugs","volume":"198","author":"Lim","year":"2019","journal-title":"Talanta"},{"issue":"6","key":"10.1016\/j.carbpol.2024.122402_bb0635","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039075","article-title":"Broader neutralizing antibodies against H5N1 viruses using prime-boost immunization of hyperglycosylated hemagglutinin DNA and virus-like particles","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.carbpol.2024.122402_bb0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v13071281","article-title":"Mutation profiles, glycosylation site distribution and codon usage Bias of human papillomavirus type 16","volume":"13","author":"Liu","year":"2021","journal-title":"Viruses"},{"issue":"13","key":"10.1016\/j.carbpol.2024.122402_bb0645","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1128\/JVI.00452-16","article-title":"Influenza virus hemagglutinin glycoproteins with different N-glycan patterns activate dendritic cells in vitro","volume":"90","author":"Liu","year":"2016","journal-title":"Journal of Virology"},{"key":"10.1016\/j.carbpol.2024.122402_bb0650","first-page":"1","article-title":"Prefusion structure of human cytomegalovirus glycoprotein B and structural basis for membrane fusion","volume":"7","author":"Liu","year":"2021","journal-title":"Science Advances"},{"issue":"11","key":"10.1016\/j.carbpol.2024.122402_bb0655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011788","article-title":"Effects of N-glycan modifications on spike expression, virus infectivity, and neutralization sensitivity in ancestral compared to omicron SARS-CoV-2 variants","volume":"19","author":"Lusvarghi","year":"2023","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.carbpol.2024.122402_bb0660","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3389\/fchem.2020.00622","article-title":"Protein Glycoengineering: An approach for improving protein properties","volume":"8","author":"Ma","year":"2020","journal-title":"Frontiers in Chemistry"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122402_bb0665","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbagen.2007.11.003","article-title":"The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance","volume":"1780","author":"Macher","year":"2008","journal-title":"Biochimica et Biophysica Acta"},{"issue":"13","key":"10.1016\/j.carbpol.2024.122402_bb0670","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1021\/ac103271w","article-title":"IR and UV photodissociation as analytical tools for characterizing lipid A structures","volume":"83","author":"Madsen","year":"2011","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.carbpol.2024.122402_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.100964","article-title":"The role of O-glycosylation in human disease","volume":"79","author":"Magalhaes","year":"2021","journal-title":"Molecular Aspects of Medicine"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122402_bb0680","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1021\/acsabm.2c01064","article-title":"Many roles of carbohydrates: A computational spotlight on the Coronavirus S protein binding","volume":"7","author":"Maity","year":"2023","journal-title":"ACS Applied Bio Materials"},{"key":"10.1016\/j.carbpol.2024.122402_bb0685","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cbpa.2017.10.021","article-title":"Glycan analysis by ion mobility-mass spectrometry and gas-phase spectroscopy","volume":"42","author":"Manz","year":"2018","journal-title":"Current Opinion in Chemical Biology"},{"key":"10.1016\/j.carbpol.2024.122402_bb0690","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.sbi.2020.12.003","article-title":"Solving the structural puzzle of bacterial glycome","volume":"68","author":"Marchetti","year":"2021","journal-title":"Current Opinion in Structural Biology"},{"key":"10.1016\/j.carbpol.2024.122402_bb0695","doi-asserted-by":"crossref","DOI":"10.3389\/fpls.2021.709344","article-title":"Site-specific glycosylation of recombinant viral glycoproteins produced in Nicotiana benthamiana","volume":"12","author":"Margolin","year":"2021","journal-title":"Frontiers in Plant Science"},{"key":"10.1016\/j.carbpol.2024.122402_bb0700","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1126034","article-title":"Glycan masking in vaccine design: Targets, immunogens and applications","volume":"14","author":"Martina","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.carbpol.2024.122402_bb0705","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/307178a0","article-title":"Human hepatitis B vaccine from recombinant yeast","volume":"307","author":"McAleer","year":"1984","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.carbpol.2024.122402_bb0710","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41576-021-00378-0","article-title":"HIV-1 and human genetic variation","volume":"22","author":"McLaren","year":"2021","journal-title":"Nature Reviews Genetics"},{"issue":"6","key":"10.1016\/j.carbpol.2024.122402_bb0715","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/(SICI)1098-2787(1998)17:6<369::AID-MAS1>3.0.CO;2-J","article-title":"Ion\/ion chemistry of high-mass multiply charged ions","volume":"17","author":"McLuckey","year":"1998","journal-title":"Mass Spectrometry Reviews"},{"issue":"7","key":"10.1016\/j.carbpol.2024.122402_bb0720","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1586\/erv.11.24","article-title":"Insect cell technology is a versatile and robust vaccine manufacturing platform","volume":"10","author":"Mena","year":"2011","journal-title":"Expert Review of Vaccines"},{"issue":"6","key":"10.1016\/j.carbpol.2024.122402_bb0725","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines9060554","article-title":"Production of SARS-CoV-2 virus-like particles in insect cells","volume":"9","author":"Mi","year":"2021","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb0730","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1038\/s41598-022-06157-z","article-title":"Conserved topology of virus glycoepitopes presents novel targets for repurposing HIV antibody 2G12","volume":"12","author":"Miller","year":"2022","journal-title":"Scientific Reports"},{"key":"10.1016\/j.carbpol.2024.122402_bb0735","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.virol.2015.03.032","article-title":"Live attenuated vaccines: Historical successes and current challenges","volume":"479-480","author":"Minor","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.carbpol.2024.122402_bb0740","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0264-410X(91)90062-B","article-title":"Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2 + S antigens","volume":"9","author":"Miskovsky","year":"1991","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.carbpol.2024.122402_bb0745","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0021-9258(19)76994-4","article-title":"The role of sialic acid in determining the survival of glycoproteins in the circulation","volume":"246","author":"Morell","year":"1971","journal-title":"Journal of Biological Chemistry"},{"issue":"47","key":"10.1016\/j.carbpol.2024.122402_bb0750","first-page":"3268","article-title":"Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies","volume":"109","author":"Mouquet","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"10.1016\/j.carbpol.2024.122402_bb0755","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/mcp.RA119.001534","article-title":"Bisecting GlcNAc is a general suppressor of terminal modification of N-glycan","volume":"18","author":"Nakano","year":"2019","journal-title":"Molecular & Cellular Proteomics"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122402_bb0760","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.toxac.2022.06.251","article-title":"Enhancing high-resolution mass spectrometry performance for NPS analysis with improved sensitivity and characterization","volume":"34","author":"Negri","year":"2022","journal-title":"Toxicologie Analytique et Clinique"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122402_bb0765","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/S2352-3018(23)00264-3","article-title":"Prophylactic HIV-1 vaccine trials: Past, present, and future","volume":"11","author":"Nkolola","year":"2024","journal-title":"The Lancet HIV"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122402_bb0770","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20040954","article-title":"Recombinant glycoprotein E of varicella zoster virus contains glycan-peptide motifs that modulate B cell epitopes into discrete immunological signatures","volume":"20","author":"Norden","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"36","key":"10.1016\/j.carbpol.2024.122402_bb0775","doi-asserted-by":"crossref","first-page":"19897","DOI":"10.1002\/anie.202106671","article-title":"Expanding the occurrence of polysaccharides to the viral world: The case of mimivirus","volume":"60","author":"Notaro","year":"2021","journal-title":"Angewandte Chemie International Edition"},{"issue":"45","key":"10.1016\/j.carbpol.2024.122402_bb0780","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1016\/j.vaccine.2014.07.115","article-title":"The Split Virus Influenza Vaccine rapidly activates immune cells through Fc\u03b3 receptors","volume":"32","author":"O\u2019Gorman","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.carbpol.2024.122402_bb0785","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.immuni.2011.05.001","article-title":"Myeloid C-type lectin receptors in pathogen recognition and host defense","volume":"34","author":"Osorio","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.carbpol.2024.122402_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2022.102348","article-title":"Glycosylation as a key parameter in the design of nucleic acid vaccines","volume":"73","author":"Ozdilek","year":"2022","journal-title":"Current Opinion in Structural Biology"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122402_bb0795","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1073\/pnas.1916131117","article-title":"Host protein glycosylation in nucleic acid vaccines as a potential hurdle in vaccine design for nonviral pathogens","volume":"117","author":"Ozdilek","year":"2020","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122402_bb0800","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.carbpol.2024.122402_bb0805","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1213256","article-title":"A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield","volume":"334","author":"Pejchal","year":"2011","journal-title":"Science"},{"issue":"7815","key":"10.1016\/j.carbpol.2024.122402_bb0810","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"issue":"50","key":"10.1016\/j.carbpol.2024.122402_bb0815","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.1016\/j.vaccine.2018.02.089","article-title":"Vaccination against the human cytomegalovirus","volume":"37","author":"Plotkin","year":"2019","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.carbpol.2024.122402_bb0820","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1093\/infdis\/jiz447","article-title":"The status of vaccine development against the human cytomegalovirus","volume":"221","author":"Plotkin","year":"2020","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.carbpol.2024.122402_bb0825","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0021-9673(00)85085-2","article-title":"Sensitive gas chromatographic determination of the glycoproteins","volume":"152","author":"Pritchard","year":"1978","journal-title":"Journal of Chromatography"},{"issue":"17","key":"10.1016\/j.carbpol.2024.122402_bb0830","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1128\/JVI.01190-15","article-title":"Cell- and protein-directed glycosylation of native cleaved HIV-1 envelope","volume":"89","author":"Pritchard","year":"2015","journal-title":"Journal of Virology"},{"issue":"10","key":"10.1016\/j.carbpol.2024.122402_bb0835","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.celrep.2015.05.017","article-title":"Structural constraints determine the glycosylation of HIV-1 envelope trimers","volume":"11","author":"Pritchard","year":"2015","journal-title":"Cell Reports"},{"key":"10.1016\/j.carbpol.2024.122402_bb0840","first-page":"1","article-title":"The essential functions and detection of bisecting GlcNAc in cell biology","volume":"8","author":"Qiushi","year":"2020","journal-title":"Frontiers in Chemistry"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb0845","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-37826-w","article-title":"Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy","volume":"14","author":"Ragonnet-Cronin","year":"2023","journal-title":"Nature Communications"},{"key":"10.1016\/j.carbpol.2024.122402_bb0850","series-title":"Advances in Glycobiotechnology","author":"Rapp","year":"2021"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122402_bb0855","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20151960","article-title":"Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design","volume":"213","author":"Rappuoli","year":"2016","journal-title":"Journal of Experimental Medicine"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122402_bb0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110217","article-title":"Mannose-binding lectin and complement mediate follicular localization and enhanced immunogenicity of diverse protein nanoparticle immunogens","volume":"38","author":"Read","year":"2022","journal-title":"Cell Reports"},{"key":"10.1016\/j.carbpol.2024.122402_bb0865","first-page":"7","article-title":"Glycosylation capacity of insect cells","volume":"81","author":"Rendi","year":"2007","journal-title":"Croatica Chemica Acta"},{"key":"10.1016\/j.carbpol.2024.122402_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2023.108206","article-title":"Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies","volume":"67","author":"Rocamora","year":"2023","journal-title":"Biotechnology Advances"},{"key":"10.1016\/j.carbpol.2024.122402_bb0875","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.01526","article-title":"Impact of vaccines; health, economic and social perspectives","volume":"11","author":"Rodrigues","year":"2020","journal-title":"Frontiers in Microbiology"},{"key":"10.1016\/j.carbpol.2024.122402_bb0880","article-title":"Proposal for a common nomenclature for sequence ions in mass spectra of peptides","volume":"11","author":"Roepstorff","year":"1984","journal-title":"Biomedical Mass Spectrometry"},{"issue":"7","key":"10.1016\/j.carbpol.2024.122402_bb0885","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1134\/S000629791307002X","article-title":"High-performance anion-exchange chromatography with pulsed amperometric detection for carbohydrate analysis of glycoproteins","volume":"78","author":"Rohrer","year":"2013","journal-title":"Biochemistry (Moscow)"},{"issue":"13","key":"10.1016\/j.carbpol.2024.122402_bb0890","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1039\/D2CC06583E","article-title":"O-GalNAc glycosylation affects the immunogenicity of the receptor-binding domain (RBD) of SARS-CoV-2 spike protein","volume":"59","author":"Rong","year":"2023","journal-title":"Chemical Communications"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb0895","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41541-023-00628-8","article-title":"Differences in HPV-specific antibody Fc-effector functions following Gardasil(R) and Cervarix(R) vaccination","volume":"8","author":"Roy","year":"2023","journal-title":"npj Vaccines"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb0900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10409239709085144","article-title":"Glycosylation: Heterogeneity and the 3D structure of proteins","volume":"32","author":"Rudd","year":"1997","journal-title":"Critical Reviews in Biochemistry and Molecular Biology"},{"issue":"17\u201318","key":"10.1016\/j.carbpol.2024.122402_bb0905","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jchromb.2010.11.013","article-title":"Derivatization of carbohydrates for GC and GC-MS analyses","volume":"879","author":"Ruiz-Matute","year":"2011","journal-title":"Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences"},{"key":"10.1016\/j.carbpol.2024.122402_bb0910","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fvets.2019.00020","article-title":"Promising plant-derived adjuvants in the development of coccidial vaccines","volume":"6","author":"Sander","year":"2019","journal-title":"Frontiers in Veterinary Science"},{"issue":"9","key":"10.1016\/j.carbpol.2024.122402_bb0915","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003618","article-title":"A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies","volume":"9","author":"Sanders","year":"2013","journal-title":"PLoS Pathogens"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122402_bb0920","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/bioengineering4020038","article-title":"Engineering of CHO cells for the production of recombinant glycoprotein vaccines with Xylosylated N-glycans","volume":"4","author":"Sandig","year":"2017","journal-title":"Bioengineering"},{"key":"10.1016\/j.carbpol.2024.122402_bb0925","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev-micro-052821-031444","article-title":"Bacterial outer membrane vesicles: From discovery to applications","volume":"75","author":"Sartorio","year":"2021","journal-title":"Annual Review of Microbiology"},{"key":"10.1016\/j.carbpol.2024.122402_bb0930","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.abo5598","article-title":"Stabilized HIV-1 envelope immunization induces neutralizing antibodies to the CD4bs and protects macaques against mucosal infection","volume":"14","author":"Saunders","year":"2022","journal-title":"Science Translational Medicine"},{"issue":"14","key":"10.1016\/j.carbpol.2024.122402_bb0935","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1128\/JVI.76.14.7306-7321.2002","article-title":"The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of \u03b11\u21922 mannose residues on the outer face of gp120","volume":"76","author":"Scanlan","year":"2002","journal-title":"Journal of Virology"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122402_bb0940","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics13040501","article-title":"Rational vaccine Design in Times of emerging diseases: The critical choices of immunological correlates of protection, vaccine antigen and immunomodulation","volume":"13","author":"Schijns","year":"2021","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.carbpol.2024.122402_bb0945","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/glycob\/cwx034","article-title":"Biological functions of fucose in mammals","volume":"27","author":"Schneider","year":"2017","journal-title":"Glycobiology"},{"issue":"8","key":"10.1016\/j.carbpol.2024.122402_bb0950","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.str.2020.04.022","article-title":"Networks of HIV-1 envelope glycans maintain antibody epitopes in the face of glycan additions and deletions","volume":"28","author":"Seabright","year":"2020","journal-title":"Structure"},{"issue":"7","key":"10.1016\/j.carbpol.2024.122402_bb0955","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/cid\/ciy1061","article-title":"The serogroup B meningococcal vaccine Bexsero elicits antibodies to Neisseria gonorrhoeae","volume":"69","author":"Semchenko","year":"2019","journal-title":"Clinical Infectious Diseases"},{"issue":"7807","key":"10.1016\/j.carbpol.2024.122402_bb0960","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.carbpol.2024.122402_bb0965","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1073\/pnas.0801340105","article-title":"Effect of glycosylation on protein folding: A close look at thermodynamic stabilization","volume":"105","author":"Shental-Bechor","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.carbpol.2024.122402_bb0970","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2174\/138945007782151360","article-title":"Protein N-glycosylation in the baculovirus insect cell system","volume":"8","author":"Shi","year":"2007","journal-title":"Current Drug Targets"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb0975","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00430-014-0374-x","article-title":"Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1\/Pre-S2\/S vaccine","volume":"204","author":"Shouval","year":"2015","journal-title":"Medical Microbiology and Immunology"},{"key":"10.1016\/j.carbpol.2024.122402_bb0980","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118919","article-title":"DNA vaccines against COVID-19: Perspectives and challenges","volume":"267","author":"Silveira","year":"2021","journal-title":"Life Sciences"},{"issue":"8","key":"10.1016\/j.carbpol.2024.122402_bb0985","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1377\/hlthaff.2020.00103","article-title":"Return on investment from immunization against 10 pathogens in 94 low-and middle-income countries, 2011-30","volume":"39","author":"Sim","year":"2020","journal-title":"Health Affairs"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb0990","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1038\/s41598-020-63052-1","article-title":"Plant-based production of highly potent anti-HIV antibodies with engineered posttranslational modifications","volume":"10","author":"Singh","year":"2020","journal-title":"Scientific Reports"},{"issue":"15","key":"10.1016\/j.carbpol.2024.122402_bb0995","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20153741","article-title":"Exploring the N-glycosylation profile of glycoprotein B from human cytomegalovirus expressed in CHO and Nicotiana tabacum BY-2 cells","volume":"20","author":"Smargiasso","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.carbpol.2024.122402_bb1000","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.coviro.2014.05.005","article-title":"Investigating virus-glycan interactions using glycan microarrays","volume":"7","author":"Smith","year":"2014","journal-title":"Current Opinion in Virology"},{"issue":"11","key":"10.1016\/j.carbpol.2024.122402_bb1005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003754","article-title":"The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies","volume":"9","author":"Sok","year":"2013","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.carbpol.2024.122402_bb1010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117489","article-title":"GC-MS analysis of the composition of serum IgG glycans as a potential diagnostic marker of advanced endometriosis - preliminary report","volume":"548","author":"Solkiewicz","year":"2023","journal-title":"Clinica Chimica Acta"},{"issue":"20","key":"10.1016\/j.carbpol.2024.122402_bb1015","doi-asserted-by":"crossref","first-page":"15717","DOI":"10.1021\/acs.chemrev.2c00118","article-title":"The astounding world of glycans from giant viruses","volume":"122","author":"Speciale","year":"2022","journal-title":"Chemical Reviews"},{"key":"10.1016\/j.carbpol.2024.122402_bb1020","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118885","article-title":"Liquid-state NMR spectroscopy for complex carbohydrate structural analysis: A hitchhiker's guide","volume":"277","author":"Speciale","year":"2022","journal-title":"Carbohydrate Polymers"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122402_bb1025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/glycob\/cwu123","article-title":"Crystal structure of the HIV neutralizing antibody 2G12 in complex with a bacterial oligosaccharide analog of mammalian oligomannose","volume":"25","author":"Stanfield","year":"2015","journal-title":"Glycobiology"},{"issue":"6","key":"10.1016\/j.carbpol.2024.122402_bb1030","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jms.3210","article-title":"Quantitative mapping of glycoprotein micro-heterogeneity and macro-heterogeneity: An evaluation of mass spectrometry signal strengths using synthetic peptides and glycopeptides","volume":"48","author":"Stavenhagen","year":"2013","journal-title":"Journal of Mass Spectrometry"},{"issue":"10","key":"10.1016\/j.carbpol.2024.122402_bb1035","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/emboj.2013.79","article-title":"Precision mapping of the human O-GalNAc glycoproteome through simple cell technology","volume":"32","author":"Steentoft","year":"2013","journal-title":"EMBO Journal"},{"key":"10.1016\/j.carbpol.2024.122402_bb1040","article-title":"Immunobiology of carbohydrates: Implications for novel vaccine and adjuvant design against infectious diseases","volume":"11","author":"Stefanetti","year":"2021","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"10.1016\/j.carbpol.2024.122402_bb1045","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0264-410X(88)90173-9","article-title":"Recombinant versus plasma derived hepatitis B vaccines-annotated","volume":"6","author":"Stephenne","year":"1988","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122402_bb1050","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.febslet.2011.01.023","article-title":"Cysteine S-glycosylation, a new post-translational modification found in glycopeptide bacteriocins","volume":"585","author":"Stepper","year":"2011","journal-title":"FEBS Letters"},{"issue":"14","key":"10.1016\/j.carbpol.2024.122402_bb1055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.00269-18","article-title":"Breadth and functionality of varicella-zoster virus glycoprotein-specific antibodies identified after Zostavax vaccination in humans","volume":"92","author":"Sullivan","year":"2018","journal-title":"Journal of Virology"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb1060","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1038\/s41467-023-39699-5","article-title":"Glycopeptide database search and de novo sequencing with PEAKS GlycanFinder enable highly sensitive glycoproteomics","volume":"14","author":"Sun","year":"2023","journal-title":"Nature Communications"},{"issue":"26","key":"10.1016\/j.carbpol.2024.122402_bb1065","doi-asserted-by":"crossref","first-page":"9528","DOI":"10.1073\/pnas.0402700101","article-title":"Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry","volume":"101","author":"Syka","year":"2004","journal-title":"PNAS"},{"issue":"12","key":"10.1016\/j.carbpol.2024.122402_bb1070","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/glycob\/cwj019","article-title":"Differential analysis of site-specific glycans on plasma and cellular fibronectins: Application of a hydrophilic affinity method for glycopeptide enrichment","volume":"15","author":"Tajiri","year":"2005","journal-title":"Glycobiology"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122402_bb1075","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201700234","article-title":"Glycoengineering in CHO cells: Advances in systems biology","volume":"13","author":"Tejwani","year":"2018","journal-title":"Biotechnology Journal"},{"key":"10.1016\/j.carbpol.2024.122402_bb1080","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0006-3495(01)76074-2","article-title":"Database analysis of O-glycosylation sites in proteins","volume":"80","author":"Thanka Christlet","year":"2001","journal-title":"Biophysical Journal"},{"issue":"10","key":"10.1016\/j.carbpol.2024.122402_bb1085","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s41422-021-00545-2","article-title":"O-glycosylation pattern of the SARS-CoV-2 spike protein reveals an \u201cO-Follow-N\u201d rule","volume":"31","author":"Tian","year":"2021","journal-title":"Cell Research"},{"issue":"15","key":"10.1016\/j.carbpol.2024.122402_bb1090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms241512054","article-title":"Evolution of vaccines formulation to tackle the challenge of anti-microbial resistant pathogens","volume":"24","author":"Tognetti","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"44","key":"10.1016\/j.carbpol.2024.122402_bb1095","doi-asserted-by":"crossref","first-page":"28557","DOI":"10.1074\/jbc.273.44.28557","article-title":"The polysialic acid units of the neural cell adhesion molecule N-CAM form filament bundle networks","volume":"273","author":"Toikka","year":"1998","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122402_bb1100","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/jvi.70.2.1100-1108.1996","article-title":"Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1","volume":"70","author":"Trkola","year":"1996","journal-title":"Journal of Virology"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122402_bb1105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/infdis\/160.2.199","article-title":"Randomized dose range study of a recombinant hepatitis B vaccine","volume":"160","author":"Tron","year":"1989","journal-title":"The Journal of Infectious Diseases"},{"issue":"10","key":"10.1016\/j.carbpol.2024.122402_bb1110","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1073\/pnas.1819197116","article-title":"Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections","volume":"116","author":"Tseng","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122402_bb1115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nchembio0207-74","article-title":"Emerging glycomis technologies","volume":"3","author":"Turnbull","year":"2007","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/j.carbpol.2024.122402_bb1120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.sbi.2020.09.009","article-title":"NMR of glycoproteins: Profiling, structure, conformation and interactions","volume":"68","author":"Unione","year":"2021","journal-title":"Current Opinion in Structural Biology"},{"issue":"9","key":"10.1016\/j.carbpol.2024.122402_bb1125","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1021\/acscentsci.9b00540","article-title":"Glycoprofile analysis of an intact glycoprotein as inferred by NMR spectroscopy","volume":"5","author":"Unione","year":"2019","journal-title":"ACS Central Science"},{"issue":"42","key":"10.1016\/j.carbpol.2024.122402_bb1130","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1016\/j.vaccine.2020.08.032","article-title":"Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present alpha-gal epitopes","volume":"38","author":"Uri","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.carbpol.2024.122402_bb1135","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/298347a0","article-title":"Synthesis and assembly of hepatitis B virus surface antigen particles in yeast","volume":"298","author":"Valenzuela","year":"1982","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb1140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1751-7915.2010.00178.x","article-title":"Vaccine development against Neisseria meningitidis","volume":"4","author":"Vogel","year":"2011","journal-title":"Microbial Biotechnology"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122402_bb1145","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/glycob\/cwl086","article-title":"Comparison of the methods for profiling glycoprotein glycans--HUPO Human Disease Glycomics\/Proteome Initiative multi-institutional study","volume":"17","author":"Wada","year":"2007","journal-title":"Glycobiology"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb1150","first-page":"127","article-title":"Binding of high-mannose-type oligosaccharides and synthetic oligomannose clusters to human antibody 2G12: Implications for HIV-1 vaccine design","volume":"11","author":"Wang","year":"2004","journal-title":"Chemistry & Biology"},{"key":"10.1016\/j.carbpol.2024.122402_bb1155","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-biochem-062917-012911","article-title":"Glycoengineering of antibodies for modulating functions","volume":"88","author":"Wang","year":"2019","journal-title":"Annual Review of Biochemistry"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122402_bb1160","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.carbpol.2024.122402_bb1165","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.abb9983","article-title":"Site-specific glycan analysis of the SARS-CoV-2 spike","volume":"369","author":"Watanabe","year":"2020","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.carbpol.2024.122402_bb1170","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.bbagen.2019.05.012","article-title":"Exploitation of glycosylation in enveloped virus pathobiology","volume":"1863","author":"Watanabe","year":"2019","journal-title":"Biochimica et Biophysica Acta"},{"issue":"9","key":"10.1016\/j.carbpol.2024.122402_bb1175","first-page":"1","article-title":"Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine","volume":"119","author":"Wu","year":"2022","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/j.carbpol.2024.122402_bb1180","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.celrep.2013.11.015","article-title":"Structural basis for enhanced HIV-1 neutralization by a dimeric immunoglobulin G form of the glycan-recognizing antibody 2G12","volume":"5","author":"Wu","year":"2013","journal-title":"Cell Reports"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122402_bb1185","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/glycob\/cwad007","article-title":"Quantitative profiling of N-glycosylation of SARS-CoV-2 spike protein variants","volume":"33","author":"Xie","year":"2023","journal-title":"Glycobiology"},{"key":"10.1016\/j.carbpol.2024.122402_bb1190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2021.114205","article-title":"High-throughput and high-sensitivity N-glycan profiling: A platform for biopharmaceutical development and disease biomarker discovery","volume":"623","author":"Xie","year":"2021","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/j.carbpol.2024.122402_bb1195","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.virusres.2013.10.015","article-title":"Efficient N-glycosylation at position 37, but not at position 146, in the street rabies virus glycoprotein reduces pathogenicity","volume":"179","author":"Yamada","year":"2014","journal-title":"Virus Research"},{"issue":"12","key":"10.1016\/j.carbpol.2024.122402_bb1200","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s40265-013-0103-6","article-title":"Recombinant trivalent influenza vaccine (flublok(\u00ae)): A review of its use in the prevention of seasonal influenza in adults","volume":"73","author":"Yang","year":"2013","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb1205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BSR20171505","article-title":"Influenza virus N-linked glycosylation and innate immunity","volume":"39","author":"York","year":"2019","journal-title":"Bioscience Reports"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122402_bb1210","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1021\/acs.bioconjchem.0c00718","article-title":"Label-free, multiplex glycan microarray biosensor for influenza virus detection","volume":"32","author":"Zhang","year":"2021","journal-title":"Bioconjugate Chemistry"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122402_bb1215","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.010587","article-title":"PEAKS DB: de novo sequencing assisted database search for sensitive and accurate peptide identification","volume":"11","author":"Zhang","year":"2012","journal-title":"Molecular & Cellular Proteomics"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb1220","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1570-0232(03)00373-8","article-title":"Determination of 1-phenyl-3-methyl-5-pyrazolone-labeled carbohydrates by liquid chromatography and micellar electrokinetic chromatography","volume":"793","author":"Zhang","year":"2003","journal-title":"Journal of Chromatography B"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb1225","article-title":"Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape","volume":"13","author":"Zhao","year":"2022","journal-title":"Nature Communications"},{"issue":"11","key":"10.1016\/j.carbpol.2024.122402_bb1230","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1021\/acs.analchem.0c00014","article-title":"Multiplexed comparative analysis of intact glycopeptides using electron-transfer dissociation and synchronous precursor selection based triple-stage mass spectrometry","volume":"92","author":"Zhu","year":"2020","journal-title":"Analytical Chemistry"},{"issue":"12","key":"10.1016\/j.carbpol.2024.122402_bb1235","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1039\/c3cs35477f","article-title":"Principles of electron capture and transfer dissociation mass spectrometry applied to peptide and protein structure analysis","volume":"42","author":"Zhurov","year":"2013","journal-title":"Chemical Society Reviews"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122402_bb1240","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.copbio.2003.12.002","article-title":"Electron-capture dissociation tandem mass spectrometry","volume":"15","author":"Zubarev","year":"2004","journal-title":"Current Opinion in Biotechnology"}],"container-title":["Carbohydrate Polymers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0144861724006283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0144861724006283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T21:03:18Z","timestamp":1732654998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0144861724006283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":248,"alternative-id":["S0144861724006283"],"URL":"https:\/\/doi.org\/10.1016\/j.carbpol.2024.122402","relation":{},"ISSN":["0144-8617"],"issn-type":[{"value":"0144-8617","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of glycosylation on viral vaccines","name":"articletitle","label":"Article Title"},{"value":"Carbohydrate Polymers","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carbpol.2024.122402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"122402"}}